bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s share price dropped 14.6% during trading on Thursday . The stock traded as low as $0.2258 and last traded at $0.2258. Approximately 1,400 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 1,233 shares. The stock had previously closed at $0.2644.
bioAffinity Technologies Stock Performance
The firm has a 50-day moving average price of $0.31 and a two-hundred day moving average price of $0.26.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Recommended Stories
- Five stocks we like better than bioAffinity Technologies
- The $5 vs. $800 Billion trade
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Trump’s AI Secret: 100X Faster Than Nvidia
- Your Bank Account Is No Longer Safe
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
